CNIH4

There are 2 papers on CNIH4 in aging research: 2 observational studies in people. The newest story, Nov 9, 2026: “DNA variants linked to inherited Alzheimer’s disease risk”.

Gene

2 papers study it1 finding

HGNCNCBI GeneTaxon

See all 2 papers on CNIH4

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“The CNIH4 locus association was driven by a missense variant (is caused by Gly54Ser, p<0·0001, odds ratio [OR] 11·99 [5·39-26·64]).”
Identification of genetic modifiers of autosomal dominant Alzheimer's disease: a genome-wide association studyThe Lancet. Neurology2026doi:10.1016/s1474-4422(26)00123-7
Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Funders: Alzheimer's Association and others
  • 1 of 1 finding with company ties
  • Humans2

Associations

1

Autosomal dominant Alzheimer's disease

upin humans1OR 11.99

1 study
  1. CNIH4 is linked with a higher risk of autosomal dominant Alzheimer's disease in humans (ADAD mutations) (OR 11.99 (5.39-26.64), p<0.0001).

    “The CNIH4 locus association was driven by a missense variant (is caused by Gly54Ser, p<0·0001, odds ratio [OR] 11·99 [5·39-26·64]).”

    HumansADAD mutations

    DNA variants linked to inherited Alzheimer’s disease risk

    The Lancet. Neurology

More on Autosomal dominant Alzheimer's disease

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 1Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months
The Lancet Neurology

DNA variants linked to inherited Alzheimer’s disease risk

One DNA variant was associated with higher disease odds, with an odds ratio of 11.99, when 101 symptomatic mutation carriers were compared with 5,050 unaffected controls.One DNA variant was associated with higher disease odds, with an odds ratio of 11.99, when 101 symptomatic mutation carriers were compared with 5,050 unaffected controls.

Genetic association · 5,151 peopleMechanisms